On the AACR Blog
Experts at the San Antonio Breast Cancer Symposium debated how the approval of a new therapeutic to treat patients with HER2-low breast cancer affects the classification and management of the disease.
Read the AACR Blog
Experts at the San Antonio Breast Cancer Symposium debated how the approval of a new therapeutic to treat patients with HER2-low breast cancer affects the classification and management of the disease.
Read the AACR Blog
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreRay Spells: Maintaining a Positive Attitude for Life Despite a History of Prostate Cancer
Read Ray’s StoryFebruary is Gallbladder and Bile Duct Cancer Awareness Month. Learn about gallbladder cancer including the treatment options.
Learn MoreCoping With Chemo Brain: Many cancer patients have problems with memory or thinking that can linger years after treatment. Researchers have new tactics that are helping people cope.
Read in Cancer TodayFebruary is National Cancer Prevention Month. Test your cancer prevention knowledge and learn about cancer risk reduction.
Take the QuizWhether honoring a special person or a special day, a donation to the American Association for Cancer Research (AACR) has a lasting impact.
Donate NowThe AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. Register to attend by the advance registration deadline of February 24, 2023.
The AACR Cancer Progress Report 2022 provides a comprehensive overview of the latest research-driven advances against the collection of devastating diseases called cancer.
Learn MoreThe AACR and its more than 50,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President Lisa M. Coussens, PhD, FAACR, discusses the research-driven advances against cancer and looks to the future of cancer science and medicine.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2020, to July 31, 2021
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018
Learn MoreYour donation to the American Association for Cancer Research helps our more than 50,000 members worldwide drive progress against cancer.
Donate Now
